Retatrutide Lyophilized Powder 60 mg
Advanced Multi-Agonist Peptide for Research
$390.00
Retatrutide is an investigational triple-receptor agonist studied for GLP-1, GIP, and glucagon signaling in metabolic research. It is not FDA-approved, but is being researched for its impact on weight-loss, appetite, or disease-treatment.
PLEASE NOTE: Peptides are intended for in vitro and analytical studies only and are not approved by the FDA for human or veterinary use or for the diagnosis, treatment, cure, or prevention of any disease.
